Related Experiment Video
Updated: Jul 3, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Recent advances in light-triggered cancer immunotherapy
Jin-Kyoung Yang1, Hayoon Kwon2,3, Sehoon Kim2,3
1Department of Chemical Engineering, Dong-eui University, Busan, 47340, Republic of Korea. yjk0627@deu.ac.kr.
Combining light-triggered cancer therapies like photodynamic therapy (PDT) and photothermal therapy (PTT) with immunotherapy enhances anti-tumor immune responses. These combined photoimmunotherapies show improved efficacy in preventing cancer recurrence and metastasis.
Area of Science:
- Oncology
- Immunology
- Biomedical Engineering
Background:
- Light-triggered phototherapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), offer minimally invasive, tumor-specific cancer treatment with low systemic toxicity.
- Phototherapies induce direct tumor cell death and stimulate anti-tumor immune responses through the release of immune-stimulating factors.
- The combination of phototherapy with cancer immunotherapy presents a synergistic approach to eradicate cancer by harnessing innate and adaptive immunity.
Purpose of the Study:
- To review recent advancements in combined photoimmunotherapies for cancer treatment.
- To elucidate the underlying anti-tumor immune response mechanisms of these combined modalities.
- To discuss current challenges and future research directions in light-triggered cancer immunotherapy.
Main Methods:
- Comprehensive literature review of recent studies on combined photoimmunotherapy.
- Analysis of different combined approaches: photoimmunotherapy (PIT), PDT-combined immunotherapy, and PTT-combined immunotherapy.
- Examination of the immunological mechanisms driving therapeutic efficacy.
Main Results:
- Combined photoimmunotherapies demonstrate superior therapeutic efficacy compared to phototherapy alone, particularly in preventing tumor recurrence and metastasis.
- These synergistic approaches effectively leverage both direct tumor cell killing and immune system activation.
- Various combined strategies, including PIT, PDT-combined immunotherapy, and PTT-combined immunotherapy, show significant promise.
Conclusions:
- Combined photoimmunotherapies represent a promising strategy for enhanced cancer eradication by integrating phototherapy with immunotherapy.
- Understanding the intricate anti-tumor immune mechanisms is crucial for optimizing these therapies.
- Further research is needed to address existing challenges and fully realize the potential of light-triggered cancer immunotherapy.
More Related Videos
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...